Botulinumneurotoxinsareafamilyofsevenbacterialtoxins(BoNT/A-G).MembersoftheBoNT family have been widely utilized for treating a growing list of medical conditions. During our previous funding cycle, we carried out the first comprehensive investigation of the effect of BoNTsonsurvivalofneurons.Weidentifiedtwoofthetoxins,BoNT/CandBoNT/E,thatinduce death of neurons. We further established that neuronal death is due to blockage of a plasma membrane recycling process by BoNT/C and E. These findings open a new line of inquiry on toxinbiologyandrevealanovelmembranerecyclingprocessessentialforneuronsurvival. Followingthesefindings,wefurtherfoundthatamyloidprecursorprotein(APP)isamajorcargo ofthemembranerecyclingprocessblockedbyBoNTs.Hereweproposemechanisticstudiesto elucidate this essential membrane recycling process at the molecular level. We will also utilize BoNTs as a novel tool to address key questions about APP recycling/processing and explore the potential role of APP in BoNT action at nerve terminals. Finally, our current studies established that SNAP-25, which is cleaved by BoNT/A, C, and E, is essential for neuron survival and APP recycling. This finding raised a significant safety concern regarding long-term useofthemajortherapeutictoxinBoNT/A,whichpromptedustodevelopalternativetherapeutic toxinsthroughproteinengineering. Our proposed studies will provide a mechanistic understanding of the effect of BoNTs on survival of neurons and may yield novel insights into APP biology. They will also address concerns about the long-term safety of current therapeutic toxins and aim to develop a new generationoftherapeutictoxinswithimprovedefficacyandsafetyinhumans.
Botulinum neurotoxins (BoNTs) are widely used to treat a growing list of medical conditions. Members of the BoNT family cause the death of neurons by blocking a plasma membrane recycling pathway. Here we seek to gain a mechanistic understanding of this critical pathway (which also contains the amyloid precursor protein involved in Alzheimer disease) and we also aimtodevelopanewgenerationoftherapeutictoxinswithimprovedefficacyinhumans.
|Masuyer, Geoffrey; Zhang, Sicai; Barkho, Sulyman et al. (2018) Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity. Sci Rep 8:4518|
|Chen, Peng; Tao, Liang; Wang, Tianyu et al. (2018) Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. Science 360:664-669|
|Zhang, Sicai; Lebreton, Francois; Mansfield, Michael J et al. (2018) Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium. Cell Host Microbe 23:169-176.e6|
|Zhang, Sicai; Berntsson, Ronnie P-A; Tepp, William H et al. (2017) Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC. Nat Commun 8:1637|
|Chevalier, Aaron; Silva, Daniel-Adriano; Rocklin, Gabriel J et al. (2017) Massively parallel de novo protein design for targeted therapeutics. Nature 550:74-79|
|Zhang, Sicai; Masuyer, Geoffrey; Zhang, Jie et al. (2017) Identification and characterization of a novel botulinum neurotoxin. Nat Commun 8:14130|
|Tao, Liang; Zhang, Jie; Meraner, Paul et al. (2016) Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 538:350-355|
|Yao, Guorui; Zhang, Sicai; Mahrhold, Stefan et al. (2016) N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Nat Struct Mol Biol 23:656-62|
|Peng, Lisheng; Adler, Michael; Demogines, Ann et al. (2014) Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins. PLoS Pathog 10:e1004177|
|Lee, Kwangkook; Zhong, Xiaofen; Gu, Shenyan et al. (2014) Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344:1405-10|
Showing the most recent 10 out of 13 publications